Volibris е определен за „ лекарство сирак “ (лекарство, използвано при редки заболявания).
Because the number of patients with PAH is low, the disease is considered ‘ rare’, and Volibris was designated an ‘ orphan medicine ’ (a medicine used in rare diseases) on 11 April 2005.